NCT04138979

Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 80 (estimated)
• Sponsor: First Affiliated Hospital of Harbin Medical University · Academic / Other
• Sex: Female
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

To date, few studies have addressed the link between gut microbiota and breast cancer chemotherapy, and previous studies have only provided a link between the gut and breast cancer.

Detailed description

To date, few studies have addressed the link between gut microbiota and breast cancer chemotherapy, and previous studies have only provided a link between the gut and breast cancer.At present, studies on the interaction mechanism between intestinal flora and breast cancer mainly focus on two aspects: first, intestinal flora affects the occurrence and progress of breast cancer by affecting estrogen metabolism;Second, intestinal flora can influence the occurrence and treatment of breast cancer by affecting the regulation of the immune system.However, the specific types (or groups) of bacteria that promote the occurrence, development and mechanism of breast cancer still need to be further studied.In addition, since most of the current clinical studies on microorganisms and breast cancer are small sample studies, the accuracy of their conclusions remains to be studied.

Conditions

• Microbiota

Interventions

Type	Name	Description
DRUG	cyclophosphamide	First use of chemotherapy after breast cancer

Timeline

• Start date: 2019-09-12
• Primary completion: 2020-10-15
• Completion: 2020-10-15
• First posted: 2019-10-25
• Last updated: 2019-10-25

Locations

1 site across 1 country: China

Regulatory

• FDA-regulated drug study